Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prolymphocytic leukemia].

P Y Dietrich1, E Pedraza, C Bayle

  • 1Service de médecine D, Institut Gustave-Roussy, Villejuif, France.

Bulletin Du Cancer
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Impact Trajectories of a Psychoeducational Program for Nursing Home Caregivers: Insights from Clinical Case Studies.

International medical case reports journal·2025
Same author

Infant botulism: Report of a misleading case and important key messages.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
Same author

Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Mdr1 gene-expression in a multidrug-resistant human non-hodgkins-lymphoma xenograft model.

International journal of oncology·2011
Same author

Cytomegalovirus colitis: an unusual cause of diarrhoea in the immunocompetent.

The journal of the Royal College of Physicians of Edinburgh·2010
Same author

Future of neurology in Pakistan.

JPMA. The Journal of the Pakistan Medical Association·2004

Prolymphocytic leukemia is a distinct chronic lymphoproliferative syndrome diagnosed by blood smear analysis. Early, aggressive treatment is crucial for both de novo cases and transformations from chronic lymphoid leukemia.

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Prolymphocytic leukemia (PLL) is a distinct lymphoid malignancy.
  • Differentiating PLL from chronic lymphoid leukemia (CLL) is essential for appropriate management.
  • PLL requires a distinct therapeutic approach compared to CLL.

Observation:

  • Morphologic, immunologic, and clinical features distinguish PLL from CLL.
  • Blood smear analysis is the primary diagnostic tool for PLL.
  • PLL can arise de novo or evolve from CLL.

Findings:

  • This review highlights the key diagnostic criteria for PLL.
  • The distinct clinical behavior of PLL necessitates specific treatment strategies.
  • Understanding the pathogenesis of PLL is key to its management.

Related Experiment Videos

Implications:

  • Accurate diagnosis of PLL ensures timely and effective treatment initiation.
  • Distinguishing de novo PLL from CLL transformation impacts prognostic assessment.
  • Further research into PLL pathogenesis may reveal novel therapeutic targets.